Stahl P D, Rodman J S, Miller M J, Schlesinger P H
Proc Natl Acad Sci U S A. 1978 Mar;75(3):1399-403. doi: 10.1073/pnas.75.3.1399.
Alveolar macrophages have been shown to bind glycoproteins and synthetic glycoconjugates (neoglycorpoteins) that have mannose, N-acetylglucosamine, or glucose in the exposed, nonreducing position. Galactose-terminal glycoproteins are not bound. Binding of radiolabeled ligands to cells is nearly completely impaired by the presence of an excess of yeast mannan. Binding is temperature sensitive and proceeds optimally at pH 7.0. Prior treatment of the cells with trypsin severely decreases their capacity to bind ligands. An inhibition assay has been developed, using radioiodinated glucose-albumin conjugate, agalacto-orosomucoid, beta-glucuronidase, and RNase B as ligands. Various glycoproteins have been shown to be effective inhibitors of ligand binding including horseradish peroxidase, agalacto-orosomucoid, beta-glucuronidase, ovalbumin, agalacto-fetuin, and RNase B. RNase A and asialo-fetuin are ineffective as antagonists. The results suggest the presence of a cell surface receptor on alveolar macrophages that binds glycoproteins having terminal sugars with the mannose or glucose configuration.
肺泡巨噬细胞已被证明能结合在暴露的非还原位置含有甘露糖、N-乙酰葡糖胺或葡萄糖的糖蛋白和合成糖缀合物(新糖蛋白)。半乳糖末端的糖蛋白不被结合。过量酵母甘露聚糖的存在几乎完全抑制了放射性标记配体与细胞的结合。结合对温度敏感,在pH 7.0时最佳。用胰蛋白酶预先处理细胞会严重降低其结合配体的能力。已开发出一种抑制试验,使用放射性碘化葡萄糖-白蛋白缀合物、去半乳糖运铁蛋白、β-葡萄糖醛酸酶和核糖核酸酶B作为配体。已证明各种糖蛋白是配体结合的有效抑制剂,包括辣根过氧化物酶、去半乳糖运铁蛋白、β-葡萄糖醛酸酶、卵清蛋白、去半乳糖胎球蛋白和核糖核酸酶B。核糖核酸酶A和脱唾液酸胎球蛋白作为拮抗剂无效。结果表明肺泡巨噬细胞表面存在一种受体,它能结合具有甘露糖或葡萄糖构型末端糖的糖蛋白。